3001 views | 5 years ago
What was once only a futuristic vision has become reality for patients and physicians seeking answers for a rare disease. Learn how whole genome sequencing can be deployed to hunt for a diagnosis and...
2837 views | 5 years ago
After seven years, dozens of specialists, dozens of genetic tests and MRIs, Sophia and her family were exhausted and without a diagnosis. They needed two years to recharge before re-engaging to end...
1801 views | 6 years ago
Watch the video to find out why laboratories In Europe have implemented VeriSeq NIPT. 1. Why did they start to think about onboarding NIPT technology? 2. The benefits of introducing Illumina NIPT 3....
1751 views | 6 years ago
Professor Andrew Beggs provides his point of view on Comprehensive Genomic Profiling (CGP), as an approach for assessing biomarkers for therapy selection and clinical trial enrollment, and why he believes...
940 views | 6 years ago
Sandip Patel, MD, from UCSD Moores Cancer Center provides his point of view on Comprehensive Genomic Profiling (CGP), as an approach for assessing biomarkers for therapy selection and clinical trial...
147787 views | 6 years ago
Get inside the latest innovation in NGS testing, Illumina patterned flow cell technology. Illumina patterned flow cell technology allows for NGS single-cell sequencing. The benefits of single-cell sequencing...
141319 views | 6 years ago
In the search for a rare disease diagnosis, whole genome sequencing has the opportunity to provide an answers earlier and can make a difference in care. Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc...
2141 views | 6 years ago
Kyle Retterer, Chief Innovation Officer at GeneDx, details how his company seamlessly integrated the DRAGEN Server into its existing on-premises solution to lower costs and reduce turnaround times,...